Latest Insider Transactions at Reata Pharmaceuticals Inc (RETA)
This section provides a real-time view of insider transactions for Reata Pharmaceuticals Inc (RETA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REATA PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REATA PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 07
2023
|
Steven Ryder Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,029
+8.49%
|
$188,697
$93.61 P/Share
|
|
Jun 07
2023
|
Shamim Ruff Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,136
+13.0%
|
$198,648
$93.61 P/Share
|
|
Jun 07
2023
|
William D. Mc Clellan Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,788
+12.12%
|
$166,284
$93.61 P/Share
|
|
Jun 07
2023
|
Christy J. Oliger Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,682
+23.21%
|
$156,426
$93.61 P/Share
|
|
Jun 07
2023
|
Martin Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,815
+12.24%
|
$168,795
$93.61 P/Share
|
|
May 16
2023
|
Michael D Wortley Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
417
-0.88%
|
$33,360
$80.99 P/Share
|
|
May 16
2023
|
Manmeet Singh Soni COO, CFO and President |
SELL
Open market or private sale
|
Direct |
625
-0.54%
|
$50,000
$80.93 P/Share
|
|
May 16
2023
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
625
-0.79%
|
$50,000
$80.94 P/Share
|
|
May 16
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
136
-0.53%
|
$11,016
$81.1 P/Share
|
|
May 16
2023
|
Samina Khan SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
352
-0.88%
|
$28,512
$81.37 P/Share
|
|
May 16
2023
|
Dawn Carter Bir Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
417
-1.33%
|
$33,360
$80.95 P/Share
|
|
May 16
2023
|
Andrea Loewen SVP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
313
-0.98%
|
$25,353
$81.02 P/Share
|
|
May 15
2023
|
Michael D Wortley Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
894
-1.86%
|
$75,096
$84.81 P/Share
|
|
May 15
2023
|
Manmeet Singh Soni COO, CFO and President |
SELL
Open market or private sale
|
Direct |
21,507
-5.4%
|
$1,806,588
$84.94 P/Share
|
|
May 15
2023
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
5,608
-3.35%
|
$476,680
$85.26 P/Share
|
|
May 15
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
950
-3.55%
|
$80,750
$85.98 P/Share
|
|
May 15
2023
|
Samina Khan SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
288
-0.72%
|
$24,480
$85.32 P/Share
|
|
May 15
2023
|
Dawn Carter Bir Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
894
-2.78%
|
$75,990
$85.09 P/Share
|
|
May 15
2023
|
Andrea Loewen SVP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
103
-0.32%
|
$8,652
$84.71 P/Share
|
|
May 12
2023
|
Andrea Loewen SVP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
6,750
-17.42%
|
$580,500
$86.26 P/Share
|
|
May 05
2023
|
Manmeet Singh Soni COO, CFO and President |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.55%
|
-
|
|
Mar 13
2023
|
Dawn Carter Bir Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
9,317
-22.44%
|
$801,262
$86.77 P/Share
|
|
Mar 10
2023
|
Shamim Ruff Director |
SELL
Open market or private sale
|
Direct |
5,740
-52.36%
|
$476,420
$83.73 P/Share
|
|
Mar 10
2023
|
Shamim Ruff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,740
+15.91%
|
$183,680
$32.28 P/Share
|
|
Mar 07
2023
|
Andrea Loewen SVP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
19,036
-16.93%
|
$1,579,988
$83.9 P/Share
|
|
Mar 07
2023
|
Andrea Loewen SVP, Global Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+20.61%
|
$405,000
$27.32 P/Share
|
|
Mar 07
2023
|
Dawn Carter Bir Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
42,042
-18.61%
|
$3,573,570
$85.88 P/Share
|
|
Mar 07
2023
|
Dawn Carter Bir Chief Commercial Officer |
BUY
Conversion of derivative security
|
Direct |
41,630
+33.25%
|
-
|
|
Mar 07
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
165
-0.61%
|
$13,860
$84.58 P/Share
|
|
Mar 07
2023
|
Manmeet Singh Soni COO, CFO and President |
SELL
Open market or private sale
|
Direct |
622
-0.7%
|
$52,248
$84.69 P/Share
|
|
Mar 07
2023
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
621
-0.73%
|
$52,164
$84.57 P/Share
|
|
Mar 07
2023
|
Samina Khan SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,961
-8.98%
|
$328,763
$83.46 P/Share
|
|
Mar 07
2023
|
Michael D Wortley Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
414
-0.85%
|
$34,776
$84.46 P/Share
|
|
Mar 06
2023
|
Dawn Carter Bir Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
54,954
-33.77%
|
$4,890,906
$89.78 P/Share
|
|
Mar 06
2023
|
Dawn Carter Bir Chief Commercial Officer |
BUY
Conversion of derivative security
|
Direct |
48,370
+33.3%
|
-
|
|
Mar 03
2023
|
R Kent Mc Gaughy Jr |
SELL
Bona fide gift
|
Indirect |
33,217
-100.0%
|
-
|
|
Mar 03
2023
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
5,286
-5.84%
|
$459,882
$87.35 P/Share
|
|
Mar 03
2023
|
Michael D Wortley Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,169
-4.28%
|
$188,703
$87.57 P/Share
|
|
Mar 03
2023
|
Andrea Loewen SVP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
1,601
-3.61%
|
$139,287
$87.73 P/Share
|
|
Mar 03
2023
|
Manmeet Singh Soni COO, CFO and President |
SELL
Open market or private sale
|
Direct |
3,587
-3.88%
|
$312,069
$87.97 P/Share
|
|
Mar 03
2023
|
Samina Khan SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,813
-6.0%
|
$244,731
$87.36 P/Share
|
|
Mar 03
2023
|
Bhaskar Anand SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
820
-2.96%
|
$71,340
$87.47 P/Share
|
|
Mar 03
2023
|
Dawn Carter Bir Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,166
-4.27%
|
$190,608
$88.25 P/Share
|
|
Mar 02
2023
|
Colin John Meyer Chief Innovation Officer |
SELL
Open market or private sale
|
Direct |
88,636
-12.49%
|
$7,711,332
$87.67 P/Share
|
|
Mar 02
2023
|
Colin John Meyer Chief Innovation Officer |
BUY
Conversion of derivative security
|
Direct |
88,636
+33.1%
|
-
|
|
Mar 02
2023
|
Andrea Loewen SVP, Global Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
218
-0.49%
|
$19,620
$90.61 P/Share
|
|
Mar 02
2023
|
Samina Khan SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
25,000
-12.58%
|
$2,100,000
$84.7 P/Share
|
|
Mar 02
2023
|
Samina Khan SVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+25.8%
|
$675,000
$27.32 P/Share
|
|
Mar 02
2023
|
James Warren Huff Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
75,000
-9.57%
|
$6,450,000
$86.4 P/Share
|
|
Mar 01
2023
|
James Warren Huff Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
75,000
+40.29%
|
-
|